 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- DYN 101 / Dynacure
Trial completion date, Trial withdrawal, Trial primary completion date: DyNaMic: Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies (clinicaltrials.gov) - Jul 12, 2022
P1/2, N=0, Withdrawn, Sponsor: Dynacure
Trial completion date: Jun 2023 --> Nov 2025 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2023 --> Sep 2025
- ||| DYN 101 / Dynacure
Trial completion date, Trial termination, Trial primary completion date: Unite-CNM: Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ? 16 Years With Centronuclear Myopathies (clinicaltrials.gov) - Jul 12, 2022
P1/2, N=16, Terminated, Sponsor: Dynacure
Trial completion date: Jun 2023 --> Nov 2025 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2023 --> Sep 2025 Trial completion date: Dec 2022 --> Jun 2022 | Recruiting --> Terminated | Trial primary completion date: Dec 2022 --> Jun 2022; Based on tolerability findings at the low dose level thus far, continuation of dosing or even dose escalation is not possible.
- | DYN 101 / Dynacure
Trial completion date, Trial primary completion date: Unite-CNM: Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ? 16 Years With Centronuclear Myopathies (clinicaltrials.gov) - Aug 30, 2021
P1/2, N=18, Recruiting, Sponsor: Dynacure
Trial completion date: Dec 2022 --> Jun 2022 | Recruiting --> Terminated | Trial primary completion date: Dec 2022 --> Jun 2022; Based on tolerability findings at the low dose level thus far, continuation of dosing or even dose escalation is not possible. Trial completion date: Apr 2022 --> Dec 2022 | Trial primary completion date: Apr 2022 --> Dec 2022
- DYN 101 / Dynacure
New P1/2 trial: DyNaMic: Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies (clinicaltrials.gov) - Feb 7, 2021
P1/2, N=9, Not yet recruiting, Sponsor: Dynacure
- | DYN 101 / Dynacure
Trial completion date, Trial primary completion date: Unite-CNM: Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ? 16 Years With Centronuclear Myopathies (clinicaltrials.gov) - May 4, 2020
P1/2, N=18, Recruiting, Sponsor: Dynacure SAS
Trial completion date: Apr 2022 --> Dec 2022 | Trial primary completion date: Apr 2022 --> Dec 2022 Trial completion date: Apr 2021 --> Apr 2022 | Trial primary completion date: Apr 2021 --> Apr 2022
- || DYN 101 / Dynacure
Enrollment open: Unite-CNM: Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ? 16 Years With Centronuclear Myopathies (clinicaltrials.gov) - Jan 21, 2020
P1/2, N=18, Recruiting, Sponsor: Dynacure SAS
Trial completion date: Apr 2021 --> Apr 2022 | Trial primary completion date: Apr 2021 --> Apr 2022 Not yet recruiting --> Recruiting
- | DYN 101 / Dynacure
New P1/2 trial: Unite-CNM: Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ? 16 Years With Centronuclear Myopathies (clinicaltrials.gov) - Jul 24, 2019
P1/2, N=18, Not yet recruiting, Sponsor: Dynacure SAS